Compare Citra Borneo Utama Tbk. (CBUT) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Borneo Utama Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp760 (market cap 2.41T, 15.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 6.8K 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 7.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Citra Borneo Utama Tbk. is more actively traded (15.2K versus 6.8K). Which is the better fit depends on your goals.
| CBUT | DGNS | |
|---|---|---|
Market Cap | 2.41T | 319B |
Volume | 15.2K | 6.8K |
Lot | 152 | 68 |
Turnover | 11.6M | 1.56M |
Average Price | 763.09 | 229 |
Value | 11.6M | 1.56M |
Indicative Equilibrium Price | 770 | 232 |
Indicative Equilibrium Volume | 300 | 200 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Borneo Utama Tbk.
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
